Basilea Pharmaceutica - PDFSEARCH.IO - Document Search Engine

Basilea Pharmaceutica
Results: 17

#	Item
1	pwc_master_logo_shortform Add to Reading List Source URL: annualreport.basilea.com Language: English - Date: 2015-03-04 10:40:28 Bacterial diseases Staphylococcaceae Pyrrolidines Basilea Pharmaceutica Ceftobiprole Methicillin-resistant Staphylococcus aureus Cephalosporin Staphylococcus aureus Nosocomial infection Bacteria Microbiology Medicine
2	Microsoft Word - 20150424_FINAL_ECCMID_EN_with links.docx Add to Reading List Source URL: www.basilea.com Language: English Antifungals Piperazines Organochlorides Triazoles Organofluorides Basilea Pharmaceutica Cephalosporin Ceftobiprole Methicillin-resistant Staphylococcus aureus Organic chemistry Chemistry Microbiology
3	Microsoft Word - 20150401_Basilea_In-licensing panRAF_EN.docx Add to Reading List Source URL: www.basilea.com Language: English Basilea Pharmaceutica Institute of Cancer Research Cancer research Cancer Research UK Medicine Cancer organizations Health
4	Microsoft Word - 20150429_Basilea_AGM15 Results_EN.docx Add to Reading List Source URL: www.basilea.com Language: English Private law Business law Committees Management Board of directors Basel Business Corporations law Basilea Pharmaceutica
5	Microsoft Word - 20150504_Basilea_Start of phase 1 panRAF_EN.docx Add to Reading List Source URL: www.basilea.com Language: English Health Association of Commonwealth Universities Institute of Cancer Research University of London Cancer research Basilea Pharmaceutica Christie Hospital Cancer Research UK Melanoma Medicine Cancer organizations Oncology
6	PDF Document Add to Reading List Source URL: reports.standardandpoors.com Language: English - Date: 2015-02-26 05:00:42 Basilea Pharmaceutica Severin Schwan 454 Life Sciences Pharmaceutical industry Business Hoffmann-La Roche Roche Diagnostics La Roche
7	PRESS RELEASE Swissmedic approves Basilea’s antibiotic Zevtera® (ceftobiprole medocaril) for the treatment of pneumonia Basel, Switzerland, December 22, 2014 – Basilea Pharmaceutica Ltd. (SIX: BSLN) reports that the Add to Reading List Source URL: www.basilea.com Language: English Infectious diseases Bacterial diseases Pneumonia Staphylococcaceae Basilea Pharmaceutica Healthcare-associated pneumonia Methicillin-resistant Staphylococcus aureus Nosocomial infection Ventilator-associated pneumonia Medicine Microbiology Bacteria
8	PRESS RELEASE Basilea announces that FDA’s Anti-Infective Drugs Advisory Committee recommends approval of isavuconazole for the treatment of invasive aspergillosis and mucormycosis Basel, Switzerland, January 22, 2015 Add to Reading List Source URL: www.basilea.com Language: English Fungal diseases Pharmaceutical sciences Basilea Pharmaceutica Prescription Drug User Fee Act Mucormycosis New Drug Application Aspergillosis Pathogenic fungi Biology Medicine Food and Drug Administration
9	PRESS RELEASE Basilea’s oncology drug candidate BAL101553 shows first evidence of antitumor activity in phase 1 study  Results of recently completed clinical phase 1 study presented at ASCO Add to Reading List Source URL: hbmpartners.com Language: English - Date: 2014-06-23 09:59:40 Pharmacology Discovery and development of tubulin inhibitors Basilea Pharmaceutica Medicine Angiogenesis
10	Area News www.baselarea.ch News from the Basel business area April 2007 Add to Reading List Source URL: www.baselarea.ch Language: English - Date: 2011-03-15 04:41:31 Basel Novartis Friedrich Miescher Institute for Biomedical Research Basilea Pharmaceutica Swiss Tropical and Public Health Institute Switzerland Museums in Basel FC Basel Cantons of Switzerland Geography of Europe Europe

UPDATE